Abstract
* Hydroxyprogesterone caproate (Makena) is the first drug approved to prevent preterm labor.
* Hydroxyprogesterone caproate is given weekly by injection to women who've had at least one premature birth.
* It's intended for use only in singleton pregnancies.
* Injection-site reactions are the most common adverse effect; others are hives, nausea, and diarrhea.